Effect of Moisturizing Creams on Skin Barrier Function
NCT00771121 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2008-10-13
Summary
This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.
Conditions
- Atopic Eczema
Interventions
- DRUG
-
urea/lactic acid
new emulsion type
- DRUG
-
only emulsion base
Sponsors & Collaborators
-
ACO Hud Nordic AB
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Sweden
Study Locations
More Related Trials
-
Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema
NCT04871711 ·Status: COMPLETED ·Phase: PHASE3
-
A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier
NCT03901144 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
NCT07146971 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer
NCT05530707 ·Status: COMPLETED ·Phase: NA
-
Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis
NCT06930365 ·Status: RECRUITING ·Phase: NA
-
Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic Dermatitis
NCT04771910 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis
NCT07205081 ·Status: RECRUITING ·Phase: PHASE1
-
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
NCT03903822 ·Status: COMPLETED ·Phase: PHASE2
-
Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin
NCT03484897 ·Status: COMPLETED ·Phase: NA
-
An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
NCT02496546 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis
NCT03250624 ·Status: COMPLETED ·Phase: PHASE2
-
A First-in-Human Study of CEE321 in Adult Subjects
NCT04612062 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
NCT05807113 ·Status: COMPLETED ·Phase: NA
-
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998 ·Status: COMPLETED ·Phase: NA
-
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
NCT07183423 ·Status: RECRUITING ·Phase: NA
-
Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis
NCT00931411 ·Status: TERMINATED ·Phase: NA
-
Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.
NCT07323719 ·Status: COMPLETED ·Phase: NA
-
Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis
NCT00356642 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
NCT02594969 ·Status: COMPLETED ·Phase: NA
-
Pimecrolimus and Epidermal Barrier Function
NCT01132079 ·Status: COMPLETED ·Phase: NA
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
NCT00354510 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis
NCT01065714 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
NCT02079688 ·Status: COMPLETED ·Phase: PHASE2